By NewsDesk  @bactiman63 Results from an international, randomized, controlled clinical trial indicate that a four-month daily treatment regimen containing high-dose, or “optimized,” rifapentine...

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections. Brian VanderVen, assistant professor of microbiology and immunology,...